Activity Measurement of 44Sc and Calibration of Activity Measurement Instruments on Production Sites and Clinics
-
Published:2023-01-31
Issue:3
Volume:28
Page:1345
-
ISSN:1420-3049
-
Container-title:Molecules
-
language:en
-
Short-container-title:Molecules
Author:
Juget Frederic1, Durán Teresa1, Nedjadi Youcef1, Talip Zeynep2ORCID, Grundler Pascal V.2ORCID, Favaretto Chiara2ORCID, Casolaro Pierluigi3ORCID, Dellepiane Gaia3ORCID, Braccini Saverio3ORCID, Bailat Claude1, van der Meulen Nicholas P.24ORCID
Affiliation:
1. Institute of Radiation Physics, 1007 Lausanne, Switzerland 2. Center of Radiopharmaceutical Sciences ETH_PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland 3. Albert Einstein Center for Fundamental Physics (AEC), Laboratory for High Energy Physics (LHEP), University of Bern, 3012 Bern, Switzerland 4. Laboratory of Radiochemistry, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland
Abstract
44Sc is a promising radionuclide for positron emission tomography (PET) in nuclear medicine. As a part of the implementation of a production site for 44Sc, precise knowledge of the activity of the product is necessary. At the Paul Scherrer Institute (PSI) and the University of Bern (UniBE), 44Sc is produced by enriched 44CaO-target irradiation with a cyclotron. The two sites use different techniques for activity measurement, namely a dose calibrator at the PSI and a gamma-ray spectrometry system at UniBE and PSI. In this work, the 44Sc was produced at the PSI, and samples of the product were prepared in dedicated containers for onsite measurements at PSI, UniBE, and the Institute of Radiation Physics (IRA) in Lausanne for precise activity measurement using primary techniques and for the calibration of the reference ionization chambers. An accuracy of 1% was obtained for the activity measurement, allowing for a precise calibration of the dose calibrator and gamma-ray spectrometry of the two production sites. Each production site now has the capability of measuring 44Sc activity with an accuracy of 2%.
Funder
Swiss National Science Fundation
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference26 articles.
1. (2021, November 01). Nucléide-LARA. Available online: http://www.lnhb.fr/donnees-nucleaires/module-lara/. 2. First-in-Human PET/CT Imaging of Metastatic Neuroendocrine Neoplasms with Cyclotron-Produced 44Sc-DOTATOC: A Proof-of-Concept Study;Singh;Cancer Biother. Radiopharm.,2017 3. Lima, T.V.M., Gnesin, S., Strobel, K., Pérez, M.D.S., Roos, J.E., Müller, C., and van der Meulen, N.P. (2021). Fifty Shades of Scandium: Comparative Study of PET Capabilities Using Sc-43 and Sc-44 with Respect to Conventional Clinical Radionuclides. Diagnostics, 11. 4. Promising prospects for 44Sc/47Sc-based theranostics: Application of 47Sc radionuclide tumor therapy in mice;Bunka;J. Nucl. Med.,2014 5. van der Meulen, N.P., Hasler, R., Talip, Z., Grundler, P.V., Favaretto, C., Umbricht, C.A., Müller, C., Dellepiane, G., Carzaniga, T.S., and Braccini, S. (2020). Developments toward the implementation of 44Sc production at a medical cyclotron. Molecules, 25.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|